Follow
Tumor associated macrophages
Tumor associated macrophages (TAMs) are a subset of myeloid-derived immune cells that cause immunosuppression in a tumor microenvironment. TAMS produce cytokines, chemical messengers that regulate immune responses, that inhibit the anti-tumor immune response thus promoting tumor growth and development.
What's Popular in Tumor associated macrophages
-
FEB 29, 2024Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe ...Written By: Brian G. MorrealeDEC 11, 2023Cancer
Oncologists have used radiation therapy for over a century to treat various types of cancer. In brief, radiation t ...Written By: Katie KokolusDEC 07, 2023Immunology
Breast cancer is one of the most common cancers diagnosed in women. According to the American Cancer Society, it is ...Written By: Brian G. MorrealeNOV 30, 2023Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre ...Written By: Brian G. MorrealeNOV 20, 2023Cancer
Phagocytosis, the biological process that destroys foreign particles and removes dead cells from circulation, represents ...Written By: Katie Kokolus
FEB 29, 2024
Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe
...
Written By:
Brian G. Morreale
DEC 11, 2023
Cancer
Oncologists have used radiation therapy for over a century to treat various types of cancer. In brief, radiation t
...
Written By:
Katie Kokolus
DEC 07, 2023
Immunology
Breast cancer is one of the most common cancers diagnosed in women. According to the American Cancer Society, it is
...
Written By:
Brian G. Morreale
NOV 30, 2023
Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre
...
Written By:
Brian G. Morreale
NOV 20, 2023
Cancer
Phagocytosis, the biological process that destroys foreign particles and removes dead cells from circulation, represents
...
Written By:
Katie Kokolus
JUL 17, 2023
Drug Discovery & Development
Introduction Antibodies are the ideal therapeutic biomolecules due to their ability to bind to a variety of targets with
...
JUN 13, 2023
Cancer
Exosomes are extracellular vesicles ranging from 30 to 150 nm in diameter that are released from various types of cells,
...
Sponsored By:
Sino Biological
MAR 27, 2023
Cancer
The tumor microenvironment (TME) consists of the cells, healthy and malignant, molecules, and blood vessels, surrounding
...
Written By:
Katie Kokolus
DEC 23, 2022
Drug Discovery & Development
Onchilles Pharma is a small pharmaceutical company based in San Diego, USA. They work in oncology pharmacy, specifically
...
Written By:
Greta Anne
-
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....MAY 19, 2022 | 8:00 AM
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...Speaker: Jeroen Krijgsveld , Nicolas Autret, PhD , Ignasi Forné, PhDSponsored By: Covaris, Inc.JUN 02, 2021 | 12:00 AM
Prostate cancers are considered immunologically ‘cold’ tumors given the very few patients who respond to checkpoint inhibitor therapy (CPI). Recently, enrichment of interferon st...
FEB 09, 2021 | 9:00 AM
Date: February 9, 2020 Time: 9:00am (PST), 12:00pm (EST) 90% of breast cancer mortality is caused by distant metastasis, a process that involves both dissemination of cancer cells to distant...
OCT 20, 2020 | 9:00 AM
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
MAY 19, 2022 | 8:00 AM
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
Speaker:
Jeroen Krijgsveld
, Nicolas Autret, PhD
, Ignasi Forné, PhD
Sponsored By: Covaris, Inc.
JUN 02, 2021 | 12:00 AM
Prostate cancers are considered immunologically ‘cold’ tumors given the very few patients who respond to checkpoint inhibitor therapy (CPI). Recently, enrichment of interferon st...
FEB 09, 2021 | 9:00 AM
Date: February 9, 2020 Time: 9:00am (PST), 12:00pm (EST) 90% of breast cancer mortality is caused by distant metastasis, a process that involves both dissemination of cancer cells to distant...
OCT 20, 2020 | 9:00 AM
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
SEP 23, 2020 | 12:00 PM
B cells and tertiary lymphoid structures (TLS) promote immunotherapy response 1:00–1:30 pm PDT Presented By: Rafet Basar, MD...
Speaker:
Handan Xiang, PhD
, Pei-Yu Chen, PhD
, Hiranmayi Ravichandran, MS
, Rafet Basar, MD
, Amir Horowitz, PhD
Presented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit
SEP 17, 2020 | 11:00 AM
In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has killed hundreds of thousands of people, including >23,000 in New York City (NYC) alone. The...
SEP 01, 2020 | 8:00 AM
DATE: September 1, 2020 TIME: 8:00am PT, 11:00am ET Nearly half of all cancer patients are eligible to receive treatment with immune checkpoint inhibitors (ICI). Thus, preventing, identifyin...
JUL 07, 2020 | 11:00 AM
Immune escape mechanisms such as the induction/recruitment of immunosuppressive cells and the increased expression of various immunosuppressive molecules including PD-1/PD-1 ligands are esse...
Speaker:
Hiroyoshi Nishikawa, MD, PhD
Presented at: Fluidigm Infectious Disease and Oncology Virtual Summit
-
OCT 19, 2022 | 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....SEP 06, 2022 | 6:00 AM PDT
Labroots to host the Microbiology Week Virtual Event Series on September 6, 2022. It offers discussions on the global development of treatment for Infectious Diseases....OCT 04, 2021 | 8:00 AM PDT
To SBI2 members and sponsors, On behalf of the Society of Biomolecular Imaging and Informatics Board of Directors, I am pleased to announce the 8th annual High Content conference which will...SEP 14, 2021 | 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...JUN 02, 2021 | 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
SEP 06, 2022
| 6:00 AM PDT
Labroots to host the Microbiology Week Virtual Event Series on September 6, 2022. It offers discussions on the global development of treatment for Infectious Diseases....
OCT 04, 2021
| 8:00 AM PDT
To SBI2 members and sponsors, On behalf of the Society of Biomolecular Imaging and Informatics Board of Directors, I am pleased to announce the 8th annual High Content conference which will...
SEP 14, 2021
| 12:00 AM PDT
Europe - 9:00 AM Central European Summer Time Americas - 9:00 AM Central Daylight Time Asia-Pacific - 9:00 AM Beijing Standard Time (*September 15) ADVANCING SCIENCE: A VIRTUAL IMMUNOLOGY CO...
JUN 02, 2021
| 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
Roche and Labroots are pleased to announce the first-ever global DISCOVERY user symposium. This two-day event will take place November 12-13, 2020 and will focus on advancements in tissue res...
April 20 - 22, 2021 05:30 am
C.E. CREDITS
Labroots is excited to announce our 9th Annual Event in the Genetics Week Virtual Event Series held on April 20-22, 2021! Genetics Week Virtual Event Series 2021 will offer a multi-day...
SEP 29, 2020
| 8:00 AM PDT
2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are...
SEP 29, 2020
| 6:00 AM PDT
Due to the fact that many large events and scientific conferences have been cancelled, we want to provide you with an outlet to present your research and learn from others in our community....